✦ LIBER ✦

Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II)

✍ Scribed by Lawrence J. Appel; Patricia R. Hebert; Jerome D. Cohen; Eva Obarzanek; Monica Yamamoto; Julie Buring; Victor Stevens; Kent Kirchner; Nemat O. Borhani

Book ID: 116172892
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 800 KB
Volume: 5
Category: Article
ISSN: 1047-2797
DOI: 10.1016/1047-2797(94)00059-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sodium reduction for hypertension preven

Sodium reduction for hypertension prevention in overweight adults: further results from the Trials of Hypertension Prevention Phase II

✍ Kumanyika, S K; Cook, N R; Cutler, J A; Belden, L; Brewer, A; Cohen, J D; Hebert 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 202 KB

Review of “angiotensin genotype, sodium

Review of “angiotensin genotype, sodium reduction, weight loss, and prevention of hypertension: Trials of hypertension prevention, phase II”

✍ Nicholas J. Schork 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 45 KB

Recruitment and Baseline Characteristics

Recruitment and Baseline Characteristics of Participants in the Dietary Approaches to Stop Hypertension Trial

✍ LAWRENCE J APPEL; WILLIAM M VOLLMER; EVA OBARZANEK; KATHY M AICHER; PAUL R CONLI 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 708 KB

Isotretinoin-basal cell carcinoma preven

Isotretinoin-basal cell carcinoma prevention trial: Design, recruitment results, and baseline characteristics of the trial participants

✍ Joseph Tangrea; Brenda Edwards; Anne Hartman; Philip Taylor; Gary Peck; Stuart S 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 955 KB

Characteristics of participants at basel

Characteristics of participants at baseline in the Treatment of Mild Hypertension Study (TOMHS)

✍ Stephen R. Mascioli; Richard H. Grimm Jr.; James D. Neaton; Jeremiah Stamler; Ro 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 510 KB

Baseline Characteristics of Participants

Baseline Characteristics of Participants in the Frequent Hemodialysis Network (FHN) Daily and Nocturnal Trials

✍ Michael V. Rocco; Brett Larive; Paul W. Eggers; Gerald J. Beck; Glenn M. Chertow 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 330 KB